Peijia Medical Ltd. (HK:9996) has released an update.
Peijia Medical Limited has announced the successful completion of its 2023 annual audit, with the audited financial results aligning with previously disclosed unaudited figures. The company’s audit, conducted by PricewaterhouseCoopers, resulted in an unqualified opinion, affirming the company’s compliance with accounting standards and regulations. Following the announcement, Peijia Medical has applied for the resumption of trading of its shares on the Stock Exchange, expected to commence on June 17, 2024.
For further insights into HK:9996 stock, check out TipRanks’ Stock Analysis page.
